Jaguar Health, Inc. ( JAGX) - Key Metrics
JAGX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $2.01 | -$6.28 | -$3.10 | -$3.10 |
| 2025Q2 | $2.94 | -$10.26 | -$6.10 | -$6.10 |
| 2025Q1 | $3.46 | -$16.70 | -$11.67 | -$11.67 |
JAGX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -0.09 |
| 2025Q2 | ? | -0.06 |
| 2025Q1 | ? | -0.07 |
JAGX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 131.99% | ? |
| 2025Q4 | -253.85% | ? |
| 2025Q3 | -134.53% | ? |
| 2025Q2 | -242.17% | ? |
| 2025Q1 | -245.27% | ? |
JAGX
Price: $2.25
52 week price:
Payout Ratio Range:
Earnings Per Share: -801.20 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 617552
Ebitda: -16.5 millionMarket Capitalization: 194589